Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy

Jennifer H. Lee, Christos S. Mantzoros, Epaminondas Sourlas et al.|The Journal of Clinical Endocrinology & Metabolism|2006

Cited by 162